April 2, 2026 - India is taking tentative steps toward legalizing industrial hemp cultivation, with recent discussions in parliament signaling a potential shift in the country’s historically strict cannabis policies. This development, reported by local and international media, could position India as a major player in the global hemp market if reforms are enacted.
Context of India’s Hemp Policy
Cannabis has been largely prohibited in India under the Narcotic Drugs and Psychotropic Substances Act of 1985, which classifies the plant as a controlled substance. However, certain states, such as Uttarakhand and Uttar Pradesh, have recently allowed limited cultivation of low-THC hemp for research and industrial purposes under strict licensing. The central government is now considering a broader framework that would expand access to hemp cultivation for textiles, paper, and other non-consumable products.
A key driver behind this shift is the recognition of hemp’s economic potential. With a vast agricultural sector and a growing need for sustainable materials, India could leverage hemp to boost rural economies and reduce reliance on synthetic fibers and imports. Additionally, global demand for hemp-based goods is prompting policymakers to revisit outdated restrictions.
Recent Developments
In late March 2026, a parliamentary committee reportedly held consultations with agricultural experts, industry representatives, and state officials to discuss a draft policy on industrial hemp. While no official legislation has been introduced, sources suggest that the government is exploring a model similar to Canada’s, where hemp is strictly regulated but widely cultivated for industrial use.
The Ministry of Agriculture has also commissioned studies to assess the feasibility of large-scale hemp farming in India’s diverse climatic zones. Early findings indicate that regions like the Himalayan foothills and central plains could be ideal for hemp cultivation, provided farmers receive adequate training and support.
Implications for the Global Hemp Market
If India moves forward with legalization, the impact on the global hemp industry could be profound. As one of the world’s largest agricultural economies, India has the potential to become a leading supplier of raw hemp materials, particularly for textiles and construction. This could drive down costs for manufacturers worldwide while creating new export opportunities for Indian farmers.
However, challenges abound. Regulatory hurdles, public stigma around cannabis, and the need for robust oversight to prevent misuse of hemp crops could slow progress. Additionally, India would need to align its policies with international standards to facilitate trade, a process that could take years.
Industry and Local Reactions
Global hemp industry leaders have expressed enthusiasm about India’s potential entry into the market. “India has the land, labor, and expertise to transform the hemp supply chain,” said a spokesperson for a European hemp trade group. “Their participation could stabilize prices and meet growing demand.”
Locally, opinions are mixed. Some farmers welcome the prospect of a new cash crop, while others worry about the risks of navigating a heavily regulated system. Advocacy groups are pushing for clear guidelines and government subsidies to ensure small-scale farmers aren’t left behind if legalization occurs.
What’s Next?
The timeline for India’s hemp policy remains uncertain, with analysts predicting that any major reforms are unlikely before 2027. In the interim, pilot programs and state-level experiments will likely serve as testing grounds for broader legalization. For now, the global hemp industry watches closely, aware that India’s decisions could reshape market dynamics in the years ahead.
This development highlights the growing recognition of hemp’s industrial value worldwide. As more countries reconsider their stance on cannabis derivatives, the industry stands to gain from expanded cultivation and innovation—provided policymakers strike the right balance between opportunity and oversight.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.